Alternative treatment of COVID 19
darren sharpe made this Official Information request to Ministry of Health
The request was partially successful.
From: darren sharpe
Dear Ministry of Health,
Can you please clarify your policy on the use of the hydrochloroquine and zinc protocol for early stage COVID19 infection cases, given that it has now been trialed in an number of other countries and when appropriate dosage is utilised, it appears to be very successful in mitigating the effects.
Can you please clarify your policy and recommendation on the use of ventilators for a more serious case of COVID19, and the protocols for progressing to ventilation rather than nebulised oxygen.
Can you please clarify your policy and recommendation with respect to flu vaccination for the 2020 season, given that various studies have shown that the individual vaccinated with a flu vaccination has an increased risk of contracting COVID19,
Can you please clarify your policy and recommendation with respect to flu vaccination for the 2020 season, given that various studies have shown an individual vaccinated will continue to shed the flu virus, which in turn may infect another person, and therefore increase that persons ability to resist COVID19
Can you please qualify your policy and recommendation with respect to the Ivermectin triple therapy protocol , which has been released in Australia for elderly and front line workers, given that the demographics of those most at risk and most impacted are the elderly and front line workers.
Ministry of Health
Kia ora Darren Sharpe
Thank you for your requests dated 22 August 2020 for information on
COVID-19. Please note that your requests have been consolidated for ease
Information in response to your queries is outlined below.
The Ministry has worked hard to ensure that information regarding COVID-19
and the Ministry’s policies and approaches is publicly available. You will
find this at:
You have specifically asked about any policy on the use of
hydroxychloroquine and zinc for early stage COVID-19 infections. The
Ministry has not formed a policy position regarding this and continues to
actively monitor international and local research, including advice from
the World Health Organization (WHO). The current advice from WHO is
Currently PHARMAC has restricted access to hydroxychloroquine to ensure it
is available for those people who need
The use of ventilators in the care of a patient with COVID-19 is a
decision that is made by the medical professionals involved given the
presenting symptoms. The Ministry does not have a policy specific to
COVID-19 and the use of ventilators or nebulised oxygen. Guidance for
medical professionals is available at:
The Ministry encourages people to get vaccinated against influenza. This
year more vaccinations were distributed nationwide than ever before. To
date, there has been no evidence from the New Zealand cases of COVID-19 to
support the position that individuals who received an influenza
vaccination have an increased risk of contracting COVID-19. Information
about the Ministry’s influenza vaccine guidance is available at:
The Ministry strongly recommends people do not use Ivermectin There is no
evidence that the compound has any efficacy against Covid-19 in humans.
This advice is explained at:
The Ministry has continued to revise its guidance around the use of
personal protective equipment. Most recently, the Ministry’s advice around
the use of face masks in public has resulted in a requirement that, from
31 August 2020, face masks must be worn when people use public transport.
Further information about wearing of face masks or face coverings is
This website also includes a link to the WHO advice on wearing a face
mask, which might be of interest to you.
You ask about the efficacy and evidence supporting the use of face masks
and the impacts of wearing them, including different varieties. There is a
range of international evidence that is publicly available. You might be
interested in the WHO's advice on the use of masks in the context of
COVID-19, which includes a summary of the evidence and lists its
references. This also includes a summary of the likely disadvantages of
the use of masks by health people, which does not include the impact on
blood oxygen levels specifically but notes that the type of material used
may lead to headaches and/or breathing issues.
You have asked about the recommendation to wear a face mask given
manufacturers have noted that "this product does not provide protection
against any virus" and "ensure professional guidance or training is
obtained to ensure correct fit of this mask". The Ministry continues to
explain that the face mask are only one part of keeping ourselves safe and
protecting others. Wearing a face mask can reduce the risk of people who
have COVID-19, spreading the virus to others. They may feel well or have
no obvious symptoms. A face mask can help stop infectious droplets
spreading when they speak, laugh, cough or sneeze. The Ministry has also
provided guidance about how to wear a face mask correctly and promoted
this through its communications channels:
You note that New Zealand’s strategy for the management and mitigation of
COVID-19 is to isolate and quarantine in order to prevent community
transmission. This is part of New Zealand’s elimination strategy. You can
read more about the pillars of the strategy at:
I trust this information fulfils your request.
Thank you for writing to the Ministry.
Office of the Director-General
Ministry of Health
E: [email address]
From: "darren sharpe"
<[FOI #13571 email]>
To: "OIA/LGOIMA requests at Ministry of Health" <[Ministry of Health request email]>
Date: 22/08/2020 08:12 pm
Subject: Official Information request - Alternative treatment of
show quoted sections
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #13571 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
show quoted sections
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
Paul Roberts left an annotation ()
For your question about hydroxychloroquine and zinc, notice how the reply said they are taking advice from WHO and point to the link https://www.who.int/news-room/q-a-detail...
That link says the WHO stopped looking at HCQ based on the data results of the Solidarity Trail. Such as reported here;
However if you go to the published paper it was later retracted;
It was retracted because the study was a fraud, designed to fail, as they only prescribed Hydroxychloroquine alone. They did not prescribe HCQ with Zinc, which is part of the protocol required to see therapeutic benefits. The medical professionals who promoted HCQ and Zinc already knew it wasn't effective to prescribe HCQ alone.
Medical professionals without a conflict of interest have conducted their own test/trials of HCQ+Zinc which are summerised here https://c19study.com/ - of the 102 studies they show the benefits of HCQ+Zinc in early stages, but no benefit for late stage hospitalization cases before mortality.
Its amazing how people in government can so easily be conned and mislead. You should reply to them outlining these facts.
Michael Vaughan left an annotation ()
Adding to the excellent annotation by Paul Roberts, I applaud you for asking the questions and now urge you to respond to the inadequacy of the replies. It is not acceptable for our MOH to casually say that they have not formed a position on treatments for which there is scientific evidence of effectiveness. If they are not satisfied with the amount or quality of the research evidence re. possible treatments which have a lengthy record of safety, they should allow doctors to prescribe those treatments to patients who want to use them, while getting on with further research as a matter of high priority. Currently doctors are being threatened with disciplinary action in this context which is outrageous.
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Paul Roberts left an annotation ()
As reported in the following OIA there were only 5 instances of using a ventilator. Unlike New York where the hospitals were getting paid $39,000 per ventilator patient, thankfully that kind of corruption did not occur in NZ.
Link to this